Central Venous Catheter
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
B. BraunGermany - Melsungen
2 programsCentral venous catheter intended to be used for children during routine clinical practiceN/A1 trial
Certofix PaedN/A
Active Trials
AngioDynamicsChina - Hong Kong
1 programBioFlo DuraMax Chronic Hemodialysis CatheterN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
B. BraunCentral venous catheter intended to be used for children during routine clinical practice
AngioDynamicsBioFlo DuraMax Chronic Hemodialysis Catheter
Interrad MedicalSecurAcath Securement System
Clinical Trials (3)
Total enrollment: 409 patients across 3 trials
NCT05124821B. BraunCentral venous catheter intended to be used for children during routine clinical practice
Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed
Start: May 2023Est. completion: Apr 2024100 patients
N/ACompleted
Access in Dialysis for Better Outcomes in Patient Therapy
Start: Aug 2016Est. completion: Jun 201992 patients
N/ACompleted
Prospective SecurAcath Subcutaneous Securement Trial
Start: Jan 2009Est. completion: May 2011217 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.